Clinical Trial Update: Development of Cockroach Immunotherapy by the Inner-City Asthma Consortium [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating cockroach allergen immunotherapy for asthma and perennial allergic rhinitis has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Perennial Allergic Rhinitis

Drugs mentioned

• Cockroach allergen immunotherapy

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Asthma, Perennial Allergic Rhinitis | Phase 1 | Status: COMPLETED | Results posted: 2014-05-23